Skip to main content

BlueYard Capital — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

67
Companies
$652.8M
Total invested
$12.8M
Avg. check
49
Industries
Biotechnology 9Software 5Food and Beverage 4Health Care 4Artificial Intelligence (AI) 3Genetics 3+43 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 67
Positive Food Co.
August 2022

Positive Foods is a food company that supplies retailers, hospitals and universities with foods

Food and Beverage · Los AngelesVenture - Series Unknown
Tephra Labs
August 2022

Tephra Labs is building infrastructure for a modern, global way of doing work.

FinTech · New York$5.0M Seed
Transcripta Bio
July 2026

Transcripta Bio is a company that focuses on drug development at a size and pace never seen before, with a lower risk.

Biotechnology · Palo Alto$24.0M Series A
Tromero
July 2023

The open platform for smarter AI

Machine Learning · London$2.0M Seed
Next Matter
June 2022

All your operations, all in one place.

Collaboration · Berlin$16.0M Series A
Change Bio
May 2025

Change Bio provides an end-to-end manufacturing solution for AI-designed and discovered recombinant proteins

Advanced Materials · London$27K Grant
ExpressionEdits
May 2024

ExpressionEdits is a biotechnology company that redesigns synthetic DNA instructions using AI, focusing on protein expression.

Artificial Intelligence (AI) · Haverhill$13.0M Seed
Grouphug
April 2025

Generates memes from the archive of group WhatsApp chats

Digital Media · Montréal$1.7M Pre-Seed
Cryptio
March 2026

Cryptio is a fintech and SaaS company that offer accounting, audit and tax software for digital assets.

Accounting · Paris$45.0M Series B
FreedomFi
March 2022

FreedomFi build cost efficient PrivateLTE networks using commodity hardware, open source software and CBRS shared spectrum.

Computer · Los Gatos$9.5M Series A
Violet
March 2023

Violet is a protocol built on ethereum.

Decentralized Finance (DeFi) · Berlin$15.0M Venture - Series Unknown
Aerska
February 2026

Aerska is a biotechnology company that is creating RNA medications to treat, delay, and prevent brain disorders.

Biotechnology · Dublin$39.0M Series A
Zafrens
February 2025

Zafrens offers a throughput platform for cell characterization, correlating molecular profiles to phenotype for accelerated drug discovery.

Biotechnology · San DiegoSeries A
Housecat
February 2022

Housecat is democratizing crypto investment strategies for users, empowering individuals to become asset managers.

Asset Management · Zug$3.4M Pre-Seed
Kindred
September 2025

The default interface for all human–AI interaction

Artificial Intelligence (AI) · Singapore$8.3M Seed
Manex
June 2025

Manex is revolutionizing process steering and industrial quality management through its manufacturing optimization agents.

Artificial Intelligence (AI) · Munich$9.1M Seed
Dance
March 2025

Dance is an e-bike subscription service where users pay a monthly fee that covers their bikes and provides an all-inclusive support package.

Consumer · Berlin$13.1M Venture - Series Unknown
Miren
February 2025

Miren is a SaaS company that offers an application deployment software.

Application Performance Management · Los Angeles$3.0M Seed
bit.bio
December 2024

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

Biotechnology · Cambridge$30.0M Venture - Series Unknown
Meatable
November 2024

Meatable is a food production company that produces guilt-free meat.

Food and Beverage · LeidenVenture - Series Unknown
CPTx
September 2024

CPTx develops single-stranded DNA products to neutralize viruses and address infectious diseases.

Biotechnology · Planegg$29.0M Venture - Series Unknown
VSPARTICLE
August 2024

VSPARTICLE develops nanoparticle generators for various applications such as sensors, batteries, catalysis, solar cells, and more.

Health Care · Delft$7.1M Series A
Insempra
May 2024

Insempra is a biotechnology-powered company enabling businesses to transform their ingredient lists with superior bio-based products.

Beauty · Planegg$20.0M Series A
Biofidelity
April 2024

Biofidelity developed a revolutionary molecular diagnostics.

Biotechnology · Cambridge$24.0M Venture - Series Unknown

Where BlueYard Capital invests

Biotechnology9
Software5
Food and Beverage4
Health Care4
Artificial Intelligence (AI)3
Genetics3

About BlueYard Capital's portfolio

How many companies has BlueYard Capital invested in?

BlueYard Capital has invested in 67 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does BlueYard Capital invest in?

BlueYard Capital's top investment sectors include Biotechnology, Software, Food and Beverage, Health Care, Artificial Intelligence (AI). The firm invests across 49 different industry categories.

What is BlueYard Capital's largest investment?

Among tracked funding rounds, Cryptio received $45.0M in a Series B round. BlueYard Capital's total known invested capital is $652.8M.

What is the average investment size for BlueYard Capital?

BlueYard Capital's average investment size is $12.8M across its portfolio of 67 companies.

What are BlueYard Capital's most recent investments?

Recent BlueYard Capital portfolio additions include Positive Food Co., Tephra Labs, Transcripta Bio, Tromero, Next Matter. These companies were founded in 2020 or later.

Reach the founders behind these 67 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →